Last reviewed · How we verify
NCT04127058
Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia
Phase 1 trial testing Iloperidone in Bipolar I Disorder in 12 participants. Completed in 27 November 2019.
27 November 2019
Quick facts
| Lead sponsor | Vanda Pharmaceuticals |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 7 October 2019 |
| Primary completion | 27 November 2019 |
| Estimated completion | 27 November 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Iloperidone (ILOPERIDONE) — full drug profile →
Conditions studied
- Bipolar I Disorder — all drugs for Bipolar I Disorder →
- Schizophrenia — all drugs for Schizophrenia →
Sponsor
Vanda Pharmaceuticals — full company profile →
Who can join
Adults 18 to 65, any sex, with Bipolar I Disorder or Schizophrenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a single-center open-label study to be conducted in the United States in subjects with bipolar I disorder or schizophrenia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04127058
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Iloperidone
Trials testing the same drug.
- NCT05648591 — Safety and Tolerability of Open-Labeled Iloperidone in Adolescents · Phase 4 · recruiting
- NCT04819776 — Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipol · Phase 3 · completed
- NCT04712734 — A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia · Phase 1 · completed
- NCT02600741 — Family Intervention in Recent Onset Schizophrenia Treatment (FIRST) · completed
- NCT01498770 — An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308) · completed
Other recruiting trials for Bipolar I Disorder
Currently open trials in the same condition.
- NCT07213466 — Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder · Phase 4 · recruiting
- NCT06433635 — Sequential Multiple Assignment Randomized Trial for Bipolar Depression · Phase 4 · active not recruiting
- NCT06221852 — Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder · NA · recruiting
- NCT05648591 — Safety and Tolerability of Open-Labeled Iloperidone in Adolescents · Phase 4 · recruiting
- NCT05427123 — Children's Bipolar Network Treatment Trial I · recruiting
Other Vanda Pharmaceuticals trials
Trials by the same sponsor.
- NCT07446439 — A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use · Phase 3 · recruiting
- NCT06804603 — A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use · Phase 2 · completed
- NCT06701396 — Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant · Phase 3 · recruiting
- NCT06494397 — Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions · Phase 1 · completed
- NCT05903924 — Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04127058 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vanda Pharmaceuticals
- Last refreshed: 13 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04127058.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing